Efficacy of zinc supplementation in reducing the incidence and prevalence of acute diarrhea--a community-based, double-blind, controlled trial
- PMID: 9250122
- DOI: 10.1093/ajcn/66.2.413
Efficacy of zinc supplementation in reducing the incidence and prevalence of acute diarrhea--a community-based, double-blind, controlled trial
Abstract
A community-based, double-blind, randomized trial was conducted in a population of low socioeconomic status in urban India to determine whether daily zinc supplementation reduces the incidence and prevalence of acute diarrhea, especially in those with zinc deficiency. Children 6-35 mo of age were randomly assigned to zinc (n = 286) and control (n = 293) groups and received a supplement daily for 6 mo. Zinc gluconate (10 mg elemental Zn) was given, with both zinc and control groups also receiving multivitamins. The primary outcome measures determined by home visits every fifth day and physician examinations were the number of acute diarrheal episodes (incidence) and total diarrheal days (prevalence). Zinc supplementation had no effect in children 6-11 mo old. In children aged > 11 mo there was significantly less diarrhea in the zinc group. In boys > 11 mo old, supplementation resulted in a 26% (95% CI: 13%, 38%) lower diarrheal incidence and a 35% (95% CI: 20%, 50%) lower prevalence. In zinc-supplemented girls > 11 mo of age, the incidence was 17% (95% CI: 2%, 30%) lower and the prevalence was 19% (95% CI: 4%, 47%) lower. Overall, zinc supplementation resulted in a 17% (95% CI: 1%, 30%) lower diarrheal incidence in children with plasma zinc concentrations < 9.18 mumol/L at enrollment and a 33% (95% CI: 6%, 52%) lower incidence in children with concentrations < 50 mumol/L. In conclusion, zinc supplementation had a significant effect on acute diarrheal morbidity in children > 11 mo old and in children with low plasma zinc concentrations.
Similar articles
-
Substantial reduction in severe diarrheal morbidity by daily zinc supplementation in young north Indian children.Pediatrics. 2002 Jun;109(6):e86. doi: 10.1542/peds.109.6.e86. Pediatrics. 2002. PMID: 12042580 Clinical Trial.
-
Zinc supplementation reduces the incidence of persistent diarrhea and dysentery among low socioeconomic children in India.J Nutr. 1996 Feb;126(2):443-50. doi: 10.1093/jn/126.2.443. J Nutr. 1996. PMID: 8632217 Clinical Trial.
-
Operational feasibility of implementing community-based zinc supplementation: impact on childhood diarrheal morbidity.Pediatr Infect Dis J. 2007 Apr;26(4):306-10. doi: 10.1097/01.inf.0000258692.65485.d9. Pediatr Infect Dis J. 2007. PMID: 17414392 Clinical Trial.
-
Zinc supplementation in public health.Ann Nutr Metab. 2013;62 Suppl 1:31-42. doi: 10.1159/000348263. Epub 2013 May 3. Ann Nutr Metab. 2013. PMID: 23689111 Review.
-
Zinc and diarrheal disease: current status and future perspectives.Curr Opin Clin Nutr Metab Care. 2008 Nov;11(6):711-7. doi: 10.1097/MCO.0b013e3283109092. Curr Opin Clin Nutr Metab Care. 2008. PMID: 18827574 Review.
Cited by
-
Effectiveness of zinc supplementation on diarrhea and average daily gain in pre-weaned dairy calves: A double-blind, block-randomized, placebo-controlled clinical trial.PLoS One. 2019 Jul 10;14(7):e0219321. doi: 10.1371/journal.pone.0219321. eCollection 2019. PLoS One. 2019. PMID: 31291305 Free PMC article.
-
Zinc treatment to under-five children: applications to improve child survival and reduce burden of disease.J Health Popul Nutr. 2008 Sep;26(3):356-65. doi: 10.3329/jhpn.v26i3.1901. J Health Popul Nutr. 2008. PMID: 18831230 Free PMC article. Review.
-
Element of caution: a case of reversible cytopenias associated with excessive zinc supplementation.CMAJ. 2003 Jul 22;169(2):129-31. CMAJ. 2003. PMID: 12874162 Free PMC article.
-
High prevalence of vitamin D insufficiency and its association with BMI-for-age among primary school children in Kuala Lumpur, Malaysia.BMC Public Health. 2011 Feb 11;11:95. doi: 10.1186/1471-2458-11-95. BMC Public Health. 2011. PMID: 21310082 Free PMC article.
-
Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years.Cochrane Database Syst Rev. 2023 Mar 30;3(3):CD009384. doi: 10.1002/14651858.CD009384.pub3. Cochrane Database Syst Rev. 2023. PMID: 36994923 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical